# 

# 

# 

## 

# 



## 

## 

|**1.**|**Annual Report of the Directors and Trustees**|**3−8**|
|---|---|---|
|1.1|Reference and Administrative Details|3|
|1.2|Structure, Governance and Management|4|
|1.3|Objectives and Activities|4|
|1.4|Public Benefit|6|
|1.5|Achievements and Performance|6|
|1.6|Financial Review|7|
|1.7|Plans for Future Periods|7|
|1.8|Acknowledgements|7|
|1.9|Auditors|8|
|1.10|Small Company Exemption|8|
|1.11|Statement of Trustees' Responsibilities|8|
|1.12|Audit Information|8|
|**2.**|**Independent Auditors' Report**|**9−11**|
|**3.**|**Financial Statements**|**12−20**|
|,3.,1|Statement of Financial Activities|12|
|3.2 '|Balanae‘Sheets|13|
|3.3|Consolidated Cashflow Statement|14|
|3.4|Notes to Financial Statements|15 −20|





## 

## 

|**Name:**|Radiology and Oncology Congresses|
|---|---|
||(sometimes abbreviated to ROC)|
||Company Registration Number: 04075344.|
||Charity Number: 1087939.|
|**Principal Office:**|Fairmount House,|
||230, Tadcaster Road, York, Y024 lES|
|**Registered Office:**|Fairmount House,|
||230, Tadcaster Road, York, Y024 lES|
|**Auditors:**|Nexia Smith & Williamson, 25 Moorgate, London EC2R 6AY|
|**Bankers:**|Unity Trust Bank, Four Brindley Place,|
||Birmingham, B1 2JB|
|**Solicitors:**|Wilsons, Alexandra House, St John's Street, Salisbury, SP1 2SB|
|**Members of the Company:**||
||The British Institute of Radiology|
||The College of Radiographers|
||The Institute of Physics and Engineering in Medicine|



## 

|Chairman|Ms P. Black|
|---|---|
|Hon. Treasurer|Dr C. J. Kotre|
|Directors|The British Institute of Radiology (resigned 9 September 2020)|
||The College of Radiographers (resigned 9 September 2020)|
||The Institute of Physics and Engineering in Medicine (resigned 9 September 2020)|
||The Royal College of Radiologists (resigned 25 October 2019)|
||Ms C. Donaldson (appointed 9 September 2020)|
||Mr R.M. Evans (appointed 9 September 2020)|
||Mr P.W. Morgan (appointed 9 September 2020)|
||Prof. S.A.P.O'Connor (appointed 9 September 2020)|
||Dr S. Redla (appointed 9 September 2020)|
||Mr I.S. Thomson (appointed 9 September 2020)|
||Dr N.J. B. Spencer, President UKI0 2020 (appointed 25 October 2019)|
||Dr J. Kabala, President UKI0 2019, (resigned 25 October 2019)|
||Mr H. B. Wilkins (resigned 25 October 2019)|
|**Honorary Officers:**||
|Marketing Support|Mr Richard Evans|
|Exhibition Support|Mrs Elizabeth Beckmann|
|**Finance Officer**|Mr John Turner|





# 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



# 

## 

## 

## 



## 

## 

## 

## 



# 

## 

## 

## 



## 

## 

|||**Company**|Company|**Group**|**•** Group|
|---|---|---|---|---|---|
|||**2020**|2019|**2020**|2019|
||**Note**|||||
|**INCOME**||||||
|**Income from**||||||
|Donations from third parties||**19**||**19**||
|Donation from subsidiary||**8,519**||||
|Investment income from subsidiary||**7,693**|10,338|||
|Interest income from banks||**4,241**|4,234|**4,241**|4,234|
|||**20,472**|14,572|**4,260**|4,234|
|**Income from Charitable Activities**||||||
|UKI0||||**50,000**|871,575|
|**Total Income**||**20,472**|14,572|**54,260**|875,809|
|**EXPENDITURE**||||||
|**Charitable activities**||||||
|Publication of Conference papers||**1,320**|8,640|**1,320**|8,640|
|UKI0|3,4,5,6 & 7|**58,909**|27,571|**284,509**|879,982|
|Impairment loss on Loan to Subsidiary|10|**182,440**||||
|**Total Expenditure**||**242,669**|36,211|**285,829**|888,622|
|**Deficit for year**||**(222,197)**|(21,639)|**(231,569)**|(12,813)|
|Fund balance brought forward||**625,203**|646,842|**633,722**|646,535|
|**Unrestricted funds Balance carried**||||||
|**forward at 30 September 2019**||**403,006**|625,203|**402,153**|633,722|
|Company Registration||||||
|Number 04075344||||||





## 

## 

|||**Company**|Company|**Group**|Group|
|---|---|---|---|---|---|
||**Notes**|**2020**|2019|**2020**|2019|
|**Fixed Assets**||||||
|Investment|8|**2**|2|IN||
|**Current Assets**||||||
|Debtors|10|**42,353**|217,100|**146,391**|87,986|
|Cash at bank and in hand||**370,723**|416,639|**424,509**|734,193|
|||**413,078**|633,731|**570,900**|822,179|
|**Creditors:** Amounts falling||||||
|due within one year|11|**10,072**|8,528|**168,747**|**188,457**|
|**Net Assets**||||||
|||**403,006**|625,203|**402,153**|633,722|
|**Reserves**||||||
|Unrestricted funds||||||
|Carried Forward||**403,006**|625,203|**402,153**|633,722|



## 





## 

## 

|**For the year ended 30 September**|**2020**||
|---|---|---|
||**2020**|2019|
|Net cash (used in) / provided by operating activities|**(309,684)**|189,162|
|Change in cash and cash equivalents in the reporting period|**(309,684)**|189,162|
|Cash and cash equivalents at the beginning of the reporting period|**734,193**|545,031|
|Cash and cash equivalents at the end of the reporting period|**424,509**|734,193|



## 

||**2020**|2019|
|---|---|---|
|Net expenditure for the reporting period|**(231,569)**|(12,813)|
|(Increase) / decrease in debtors|**(58,405)**|146,324|
|(Decrease) / increase in creditors|**(19,710)**|55,651|
|Net cash (used in)! provided by operating activities|**309,684**|189,162|
|**Analysis of cash and cash equivalents**|||
|Cash in hand|**424,153**|734,193|
|Total cash and cash equivalents|**424,153**|734,193|





## 

## 

## 

## 

## 

## 

## 



## 



# 

## 

## 

## 

||||**2020**||
|---|---|---|---|---|
||**£**|**£**|**£**|**£**|
||**Direct**|**Admin**|**Governance**|**Total**|
|Publishing current year's conference papers|**1,320**|**−**||**1,320**|
|UKI0 2020 (note 5)|**217,536**|**8,064**|**58,909**|**284,509**|
||218,856|8,064|58,909|285,829|
||||2019||
||£|£|£|£|
||Direct|Admin|Governance|Total|
|Publishing prior year's conference papers|8,640|||8,640|
|UKI0 2019 (note 5)|840,360|12,051|27,571|879,982|
||849,000|12,051|27,571|888,622|



## 

|||**2020**|2019|
|---|---|---|---|
|Direct|Venue Costs|**66,396**|311,506|
|Other|Event Costs|**151,140**|528,854|
|**Total **|**UKI0 Costs**|**217,536**|840,360|





## 

|**Deficit on Ordinary Activities −Group**|||
|---|---|---|
|The deficit is stated after charging:|**2020**|2019|
|Auditors' remuneration: Audit (excluding VAT)|**9,414**|8,835|
|Non−Audit (excluding VAT)|**900**|900|
|Directors' and Officers' Insurance|**1,889**|1,850|



## 

## 

|||**Company **|**/ **|**Charity**|
|---|---|---|---|---|
|||**2020**||2019|
|Total|investment|**£2**||£2|



||**2020**|2019|
|---|---|---|
||**E**|**E**|
|Aggregate Assets|**200,176**|405,549|
|Aggregate Liabilities|**(382,616)**|(397,028)|
|Reserves|**(182,440)**|8,521|
|Total Income|**50,000**|871,575|
|Total Expenditure|**(243,360)**|(862,749)|
|(Loss)/ Profit for year|**(193,360)**|8,826|





## 

|**Debtors**|**Company / Charity**|**Company / Charity**|**Group**||
|---|---|---|---|---|
||**2020**|2019|**2020**|2019|
||£|£|£|£|
|Trade debtors|||**5,365**|27,989|
|Amounts owed by group undertakings|**224,793**|217,100|||
|Less: Provision for doubtful debts|**(182,440)**||||
|Prepayments|||**99,637**|23,260|
|VAT repayment|−||**41,389**|36,741|
||**42,353**|217,100|**146,391**|87,986|



|**Creditors**|**Company / Charity**|**Company / Charity**|**Group**||
|---|---|---|---|---|
||**2020**|2019|**2020**|2019|
||£|£|£|£|
|Trade creditors|−||**142,003**|16,349|
|Deferred Income and Accruals|**10,072**|8,528|**26,744**|172,108|
||**10,072**|8,528|**168,747**|188,457|



|||**Company I Charity**|**Company I Charity**|**Group**||
|---|---|---|---|---|---|
|||**2020**|2019|**2020**|2019|
|||£|£|**£**|**£**|
|**Carrying **|**value of Financial Assets**|||||
|Financial|assets at amortised cost|**42,353**|217,102|**5,365**|27,989|
|**Carrying **|**value of Financial liabilities**|||||
|Financial|liabilities at amortised cost|**10,072**|8,528|**168,747**|188,457|





## 

## 

## 

## 

##